Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...

The dip was slight but was the first such decline in a decade. Separately, a study links Ozempic with an increased risk of a rare form of vision loss, and another study links seed oils with an ...

Semaglutide and other GLP-1 meds slow the rate at which food empties from your stomach, and that leaves you feeling full ...

The fundamentals of Novo and Lilly do look robust, but it is always wise to avoid putting all of your eggs in one basket.

It's been six months since I accidentally poisoned myself with a weight-loss jab I shouldn't have taken. But while the memory ...

The marketing initiative touts the protein and fiber content of the offerings, which appeals to consumers taking weight-loss ...

The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

Copenhagen: Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight loss treatments Ozempic and Wegovy, said Monday it was investing ...

Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was ...

Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, which have gained ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...